These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20536956)

  • 1. Risks of marathon running and hypoglycaemia in Type 1 diabetes.
    Graveling AJ; Frier BM
    Diabet Med; 2010 May; 27(5):585-8. PubMed ID: 20536956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
    Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP;
    Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
    de Galan BE; Schouwenberg BJ; Tack CJ; Smits P
    Neth J Med; 2006 Sep; 64(8):269-79. PubMed ID: 16990690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of hypoglycemia in patients with type 1 diabetes].
    Radermecker RP; Jandrain B; Paquot N; Philips JC; Contessi E; Lavigne M; Rinaldi AM; Scheen AJ
    Rev Med Liege; 2003 Jun; 58(6):361-8. PubMed ID: 12945232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risks of nocturnal hypoglycaemia in insulin-treated diabetes.
    Graveling AJ; Frier BM
    Diabetes Res Clin Pract; 2017 Nov; 133():30-39. PubMed ID: 28888993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How hypoglycaemia can affect the life of a person with diabetes.
    Frier BM
    Diabetes Metab Res Rev; 2008 Feb; 24(2):87-92. PubMed ID: 18088077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes.
    Wright RJ; Macleod KM; Perros P; Johnston N; Webb DJ; Frier BM
    Diabet Med; 2007 Sep; 24(9):1039-42. PubMed ID: 17559427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
    Schiel R; Ulbrich S; Müller UA
    Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
    Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
    Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.
    Arutchelvam V; Heise T; Dellweg S; Elbroend B; Minns I; Home PD
    Diabet Med; 2009 Oct; 26(10):1027-32. PubMed ID: 19900235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index).
    Pérez-Maraver M; Caballero-Corchuelo J; Boltana A; Insa R; Soler J; Montanya E
    Acta Diabetol; 2013 Aug; 50(4):529-35. PubMed ID: 21874353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycaemia: current management and controversies.
    Choudhary P; Amiel SA
    Postgrad Med J; 2011 Apr; 87(1026):298-306. PubMed ID: 21296797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM; Graveling AJ; Frier BM
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin binding to antibodies is a risk factor for inexplicable severe hypoglycaemia in children with type-1 diabetes mellitus.
    Seewi O; Jaeger C; Bretzel RG; Schönau E
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):293-7. PubMed ID: 18484562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypoglycemia--a dreaded complication of diabetes].
    Bjørgaas M
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2441-4. PubMed ID: 11475234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemia in the diabetic child.
    Soltész G
    Baillieres Clin Endocrinol Metab; 1993 Jul; 7(3):741-55. PubMed ID: 8379914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review.
    Barendse S; Singh H; Frier BM; Speight J
    Diabet Med; 2012 Mar; 29(3):293-302. PubMed ID: 21838763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.